Fingerprint
Dive into the research topics of 'Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically